Facilitated By

San Antonio Medical Foundation


  • Idorsia: A Swiss Biotech Poised For Fantastic Growth

    With this article, I wish to introduce my readers to a biotech with only a ... But at the end, I think you will agree - Idorsia (OTCPK:IDRSF) is a biotech with a .... Phase 2 data on 360 patients at the SLEEP conference held in San Antonio.

  • Pet Talk: The benefits of a balanced microbiome

    Dr. Audrey Cook, an associate professor at the Texas A&M College of Veterinary Medicine & Biomedical Sciences, discusses the importance of a ...

  • Buyer of RK Group Property Planning Major East Side Development

    The proposed redevelopment would mark a significant investment in San Antonio's near East Side, which has seen residential redevelopment in ...

  • In memoriam: UTSA founding faculty and professor emeritus Paul H. Rodríguez dies at age 81

    He served as program director for the Minority Biomedical Research ... student attending a SACNAS conference in San Antonio in the late 80s.

  • Initial public offerings scheduled to debut next week

    Business: Late-stage biotech developing therapies for rare cholestatic liver diseases. Phreesia - New York, 7.8 million shares, priced $15-$17, ...